• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

D环氧化螺内酯。螺内酯人体代谢产物的表征。

Ring D oxygenated Spirolactones. Characterization of human metabolic product of spironolactone.

作者信息

Chinn L J, Brown E A, Mizuba S S, Karim A

出版信息

J Med Chem. 1977 Mar;20(3):352-5. doi: 10.1021/jm00213a008.

DOI:10.1021/jm00213a008
PMID:845867
Abstract

15alpha-Hydroxycanrenone (1b) was prepared from canrenone (1a) by microbiological oxidation with a penicillium species. The product was identical with one obtained from the metabolism of spironolactone(3) in human. Oxidation of 1b with Jones regent furnished the corresponding 15-oxocanrenone (1d) which underwent base-catalyzed beta elimination to generate an alpha,beta-unsaturated cyclopentenone system. 15alpha-Hydroxycanrenone (1b) failed to show antimineralocorticoid activity at the screening dose of 2.4 mg while the oxo derivative 1d exhibited approximately 15% the activity of 3. Since the activity of canrenone is 38% that of spironolactone, introduction of the carbonyl group at the 15 position of canrenone resulted in a reduction in activity. This effect is opposite to that observed with 6-dehydroprogesterone.

摘要

15α-羟基坎利酮(1b)由坎利酮(1a)通过青霉菌进行微生物氧化制备而成。该产物与人体内螺内酯(3)代谢产生的产物相同。用琼斯试剂氧化1b得到相应的15-氧代坎利酮(1d),其在碱催化下发生β消除反应,生成α,β-不饱和环戊烯酮体系。15α-羟基坎利酮(1b)在2.4毫克的筛选剂量下未表现出抗盐皮质激素活性,而氧代衍生物1d的活性约为3的15%。由于坎利酮的活性为螺内酯的38%,在坎利酮的15位引入羰基会导致活性降低。这种效应与6-脱氢孕酮所观察到的相反。

相似文献

1
Ring D oxygenated Spirolactones. Characterization of human metabolic product of spironolactone.D环氧化螺内酯。螺内酯人体代谢产物的表征。
J Med Chem. 1977 Mar;20(3):352-5. doi: 10.1021/jm00213a008.
2
[Aspects of the physiologic bioavailability of spironolactone and canrenone].[螺内酯和坎利酮的生理生物利用度方面]
Sem Hop Ther. 1976 Nov;52(9):465-70.
3
Is canrenone the major metabolite of spironolactone?
Clin Pharm. 1983 May-Jun;2(3):209-10.
4
The metabolism of canrenone in vitro by rat liver preparations.坎利酮在大鼠肝脏制剂中的体外代谢。
Xenobiotica. 1981 Apr;11(4):231-40. doi: 10.3109/00498258109045297.
5
Application of a simple fluorometric method on absorption of canrenone.一种简单荧光法在坎利酮吸收方面的应用。
Int J Clin Pharmacol Biopharm. 1976 Mar;13(2):123-6.
6
Pharmacokinetics of canrenone after oral administration of spironolactone and intravenous injection of canrenoate-K in healthy man.健康男性口服螺内酯及静脉注射坎利酸钾后坎利酮的药代动力学
Eur J Clin Pharmacol. 1983;25(4):449-53. doi: 10.1007/BF00542109.
7
Effects of spironolactone, canrenone and canrenoate-K on cytochrome P450, and 11beta- and 18-hydroxylation in bovine and human adrenal cortical mitochondria.螺内酯、坎利酮和坎利酸钾对牛和人肾上腺皮质线粒体中细胞色素P450以及11β-和18-羟化作用的影响。
Endocrinology. 1976 Oct;99(4):1097-106. doi: 10.1210/endo-99-4-1097.
8
Pharmacokinetics of canrenone and metabolites after base hydrolysis following single and multiple dose oral administration of spironolactone.螺内酯单剂量和多剂量口服给药后经碱水解的坎利酮及其代谢物的药代动力学。
Eur J Clin Pharmacol. 1984;27(4):441-6. doi: 10.1007/BF00549592.
9
The influence of age and multimorbidity on the pharmacokinetics and metabolism of spironolactone.年龄和多种疾病对螺内酯药代动力学及代谢的影响。
Arch Gerontol Geriatr. 1984 Jul;3(2):147-59. doi: 10.1016/0167-4943(84)90006-2.
10
Biotransformation of the mineralocorticoid receptor antagonists spironolactone and canrenone by human CYP11B1 and CYP11B2: Characterization of the products and their influence on mineralocorticoid receptor transactivation.盐皮质激素受体拮抗剂螺内酯和坎利酮在人CYP11B1和CYP11B2作用下的生物转化:产物表征及其对盐皮质激素受体反式激活的影响
J Steroid Biochem Mol Biol. 2016 Oct;163:68-76. doi: 10.1016/j.jsbmb.2016.04.004. Epub 2016 Apr 25.